Every material Form 8-K Astera Labs has filed with the SEC since June 24, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Astera Labs disclosed that director Michael Hurlston resigned from its Board of Directors and all committees, effective November 3, 2026, after notifying the company on November 2, 2026. The filing states there were no disagreements with the company and that the resignation was not related to its operations, policies or practices.
Michael Hurlston resigned as a board member and from any committees, effective November 3, 2026
Notice of resignation was given to the company on November 2, 2026
Filing states no disagreements with the company and no link to operations, policies or practices
Astera Labs announced financial results for the third quarter ended September 30, 2026, delivering record quarterly revenue of $584.9 million alongside GAAP net income of $182.9 million. The company also issued its financial outlook for the fourth quarter of 2026, projecting revenue between $730 million and $750 million.
Q3 2026 revenue reached a record $584.9 million, up 154% year-over-year.
GAAP net income for the third quarter was $182.9 million, or $0.99 per diluted share.
Q4 2026 revenue is projected to be in the range of $730 million to $750 million.
Astera Labs reported second-quarter 2026 revenue of $392.4 million, up 27% from the first quarter and 104% from a year earlier, with GAAP net income of $153.1 million, or $0.83 per diluted share. The company guided third-quarter 2026 revenue to $540 million to $560 million and GAAP diluted EPS to $0.87 to $0.92, and said Scorpio fabric switches are expected to become its largest product family one quarter ahead of prior expectations.
Q2 2026 GAAP net income was $153.1 million, or $0.83 per diluted share, versus $51.2 million, or $0.29, in Q2 2025; results include a $50.3 million income tax benefit.
Q2 2026 GAAP gross margin was 73.3% and GAAP operating income was $89.2 million, a 22.7% operating margin.
Q2 2026 non-GAAP diluted EPS was $0.80, compared with $0.44 in Q2 2025.
Q3 2026 outlook calls for revenue of $540 million to $560 million and GAAP diluted EPS of $0.87 to $0.92 on about 185 million weighted-average diluted shares.
Astera Labs reported record first-quarter 2026 revenue of $308.4 million, up 14% from the prior quarter and 93% from a year earlier, with GAAP diluted earnings per share of $0.44 against $0.18 a year earlier. The company forecast second-quarter 2026 revenue of $355 million to $365 million and GAAP diluted EPS of $0.44 to $0.46, which gives shareholders a revenue outlook above the first-quarter result.
Q1 2026 revenue of $308.4 million, up 14% sequentially and 93% year-over-year
GAAP net income of $80.3 million and GAAP diluted EPS of $0.44, versus $0.18 a year earlier; net income included a tax benefit of $6.9 million
GAAP operating income of $61.8 million, down from $67.0 million in the fourth quarter of 2025 but up from $11.3 million a year earlier
Q2 2026 outlook: revenue of $355 million to $365 million and GAAP diluted EPS of $0.44 to $0.46
Astera Labs said CFO Michael Tate will retire effective March 2, 2026, and will serve as Strategic Advisor to the CEO until September 1, 2026. The company named Desmond Lynch, formerly CFO of Rambus, as his successor effective the same date, with a base salary of $500,000 and equity awards with a combined target value of $9,000,000.
Michael Tate retires as CFO effective March 2, 2026; he stays on as Strategic Advisor to the CEO until September 1, 2026
Desmond Lynch, age 46, becomes CFO effective March 2, 2026, after serving as SVP, Finance and CFO of Rambus Inc. from August 2022 until February 2026
Lynch's offer letter includes a $500,000 base salary, a 95% bonus target, and RSU and PSU awards totaling $9,000,000 in target value
The company states Tate's retirement was not related to its operations, policies or practices, and that there were no disagreements
Astera Labs reported fourth-quarter 2025 revenue of $270.6 million, up 17% from the prior quarter and 92% from a year earlier, and full-year 2025 revenue of $852.5 million, up 115%. GAAP net income for the quarter was $45.0 million, or $0.25 per diluted share, down from $91.1 million, or $0.50, in the third quarter, while GAAP net income for the full year was $219.1 million. The company guided first-quarter 2026 revenue to $286 million to $297 million and GAAP diluted EPS to $0.36 to $0.38.
Q4 2025 revenue $270.6 million, up 17% sequentially and 92% year-over-year
Q4 2025 GAAP net income $45.0 million, or $0.25 diluted EPS, versus $91.1 million and $0.50 in Q3 2025
Astera Labs agreed on February 5, 2026 to issue Amazon a warrant to buy up to 3,262,299 shares of common stock at $142.82 per share. The warrant vests only as Amazon and its affiliates make specified purchases of Astera's products, up to a total of $6.5 billion, so it ties the equity grant to customer spending. Shareholders may face dilution if the warrant is exercised, and the filing does not state a current financial result.
Warrant covers up to 3,262,299 common shares at $142.82 per share, exercisable through February 5, 2033
Vesting depends on purchases by Amazon and affiliates of smart fabric switch, signal conditioning and optical engine products, up to $6.5 billion
Warrant issued without SEC registration under Section 4(a)(2), which the company says is exempt; the warrant holder has no voting rights while unexercised
Astera Labs appointed Germaine Cota as Chief Accounting Officer and Vice President of Finance, and as its principal accounting officer, effective January 20, 2026. She previously served as Senior Vice President, Finance & Accounting at BILL Holdings, Inc. The filing describes an initial base salary and equity awards, which is a routine officer appointment with limited direct financial impact on shareholders.
Germaine Cota, age 45, appointed Chief Accounting Officer effective January 20, 2026
Initial annual base salary of $375,000 with a 50% performance bonus target
One-time hiring or relocation bonus of $130,000, subject to recoupment if she leaves within a year
RSU awards with an aggregate opportunity of $3.5 million (long-term) and $500,000 (supplemental)
Astera Labs reported record third-quarter 2025 revenue of $230.6 million, up 20% from the prior quarter and 104% from a year earlier, and GAAP net income of $91.1 million, compared with a net loss of $7.6 million in the third quarter of 2024. The quarter's net income included a GAAP income tax benefit of $24.3 million. The company also guided fourth-quarter revenue to $245 million to $253 million and said it entered a definitive agreement to acquire aiXscale Photonics GmbH.
GAAP diluted EPS of $0.50 and GAAP net income of $91.1 million, versus a net loss of $7.6 million a year earlier
Non-GAAP diluted EPS of $0.49, excluding stock-based compensation expense of $40.7 million in the quarter
Fourth-quarter 2025 outlook: revenue of $245 million to $253 million and GAAP diluted EPS of approximately $0.20
Definitive agreement to acquire aiXscale Photonics GmbH; the filing does not disclose the purchase price
Astera Labs reported second-quarter 2025 revenue of $191.9 million, up 20% from the first quarter and 150% from a year earlier, with GAAP net income of $51.2 million and GAAP diluted earnings per share of $0.29. The company forecast third-quarter 2025 revenue of $203 million to $210 million and GAAP diluted earnings per share of $0.23 to $0.24, which is below the second-quarter GAAP figure. Shareholders get a higher revenue and profit base for the quarter, along with a third-quarter outlook that points to lower GAAP earnings per share than the second quarter reported.
Q2 2025 revenue was $191.9 million, up 20% sequentially and 150% year over year
GAAP net income was $51.2 million, or $0.29 per diluted share, versus $0.18 per diluted share in the prior quarter ended March 31, 2025
Non-GAAP diluted EPS was $0.44 for the quarter; GAAP operating margin was 20.7%
Q3 2025 outlook: revenue of $203 million to $210 million and GAAP diluted EPS of $0.23 to $0.24
Astera Labs reported first-quarter 2025 results for the period ended March 31, 2025, with revenue of $159.4 million, up 13% from the prior quarter and 144% from a year earlier. GAAP net income was $31.8 million, or $0.18 per diluted share, compared with a net loss of $93.0 million a year earlier. The company also guided second-quarter revenue to $170 million to $175 million, which would extend growth for shareholders if achieved.
Q1 2025 revenue of $159.4 million, up 13% sequentially and 144% year-over-year
GAAP net income of $31.8 million and diluted EPS of $0.18, versus a net loss of $93.0 million and EPS of $(1.77) in Q1 2024
Non-GAAP diluted EPS of $0.33 for Q1 2025
Q2 2025 outlook: revenue of $170 million to $175 million; GAAP diluted EPS of $0.10 to $0.11
Astera Labs increased its board from seven to eight members and appointed Dr. Craig Barratt as a director effective March 2, 2025. He also replaced Manuel Alba on the Audit Committee, and the board classed him as independent. The filing describes a routine board addition with a standard director compensation package.
Craig Barratt appointed to the Board effective March 2, 2025; board increased from seven to eight directors
Replaces Manuel Alba on the Audit Committee; Barratt designated a Class II director, expected to stand for election at the 2026 Annual Meeting
Compensation: $60,000 annual Board retainer, $12,500 annual Audit Committee retainer (prorated for 2025), and a one-time RSU award with a fair market value of $330,000 vesting in equal annual installments over three years
Astera Labs reported preliminary fourth-quarter 2024 revenue of $141.1 million, up 25% from the prior quarter and up 179% from a year earlier, and GAAP net income of $24.7 million, or $0.14 per diluted share. For full-year 2024, revenue was $396.3 million, but the company reported a GAAP net loss of $83.4 million, which included $88.9 million of stock-based compensation tied to its IPO. The company also projected first-quarter 2025 revenue of $151 million to $155 million, which would be above the fourth-quarter level.
Q4 2024 revenue of $141.1 million, up 25% sequentially and up 179% year over year; GAAP net income of $24.7 million, or $0.14 per diluted share
Full-year 2024 revenue of $396.3 million, up 242%; GAAP net loss of $83.4 million, or $0.64 per share
Q1 2025 outlook: revenue of $151 million to $155 million; GAAP diluted EPS of $0.03 to $0.04; non-GAAP diluted EPS of $0.28 to $0.29
Astera Labs entered a lease on December 16, 2024, for about 154,231 square feet of office space in San Jose, California, to become its new corporate headquarters after construction and expiry of its current lease, estimated in the second quarter of 2025. The filing describes an initial monthly base rent of $385,577.50 with annual increases of about 3%, and a construction allowance of $8,482,705, which can rise to $11,567,325.
Lease covers about 154,231 square feet across three San Jose buildings, with an initial term of 90 months from the Commencement Date.
Initial monthly base rent is $385,577.50, scheduled to rise about 3% per year.
Construction allowance is $8,482,705, with a right to increase it to $11,567,325.
Rent begins on the Rent Commencement Date; the term starts no earlier than April 1, 2025.
Astera Labs reported record third-quarter fiscal 2024 revenue of $113.1 million, up 47% from the prior quarter and up 206% from a year earlier, in an 8-K furnished November 4, 2024. The company posted a GAAP net loss of $7.6 million, or $0.05 per share, and non-GAAP diluted earnings of $0.23 per share, and it gave fourth-quarter revenue guidance of $126 million to $130 million.
Q3 revenue of $113.1 million, up from $76.9 million in Q2 2024 and $36.9 million in Q3 2023
GAAP operating loss narrowed to $8.9 million from $24.3 million in the prior quarter; GAAP net loss was $7.6 million
Non-GAAP diluted EPS of $0.23, compared with $0.13 in Q2 2024
Q4 2024 outlook: revenue of $126 million to $130 million and GAAP gross margin of approximately 75%
Astera Labs reported second-quarter 2024 revenue of $76.9 million, up 18% from the first quarter and 619% from a year earlier. GAAP net loss narrowed to $7.5 million, or $0.05 per share, from $93.0 million in the first quarter, which included IPO-related stock-based compensation. The company expects third-quarter revenue of $95 million to $100 million, and IPO lock-up restrictions on officers, directors and major holders are expected to end at the open of trading on August 8, 2024.
Q2 revenue of $76.9 million, up 18% sequentially and 619% year over year
GAAP net loss of $7.5 million, or $0.05 per share, versus a $93.0 million net loss in Q1 2024
Non-GAAP net income of $22.2 million, or $0.13 per diluted share
Q3 2024 revenue outlook of $95 million to $100 million; lock-up restrictions expected to end August 8, 2024
Astera Labs increased its board from six to seven directors and appointed Bethany Mayer, a former Ixia CEO, as an independent Class I director effective June 23, 2024. Her Audit Committee seat, replacing Stefan Dyckerhoff, takes effect July 25, 2024. The filing reports no financial results, and the appointment is a governance change that adds a director with networking and cybersecurity board experience.
Board expanded from six to seven directors; Mayer appointed effective June 23, 2024
Mayer joins Audit Committee effective July 25, 2024, replacing Stefan Dyckerhoff
Director pay includes a $60,000 prorated annual Board retainer and a $12,500 prorated Audit Committee retainer
One-time RSU award with a fair market value of $330,000, vesting in equal annual installments over three years
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Astera Labs filing is on SEC EDGAR ↗. 8-K briefs of other companies →